Zimmer latest medtech to warn of delta wave drag in Q3

Zimmer Biomet has become the latest medical device company to warn that the U.S. delta variant wave is putting pressure on its business.
With sales growing slowly sequentially so far in the quarter, Zimmer has retained its full-year guidance but said it is likely to land toward the bottom of the range. The company expects the pressure to drag on into the fourth quarter.